You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,007,208


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,007,208 protect, and when does it expire?

Patent 11,007,208 protects VEKLURY and is included in one NDA.

Protection for VEKLURY has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-two patent family members in twenty-three countries.

Summary for Patent: 11,007,208
Title:Methods for treating arenaviridae and coronaviridae virus infections
Abstract: Provided are methods for treating Arenaviridae and Coronaviridae virus infections by administering nucleosides and prodrugs thereof, of Formula I: ##STR00001## wherein the 1' position of the nucleoside sugar is substituted. The compounds, compositions, and methods provided are particularly useful for the treatment of Lassa virus and Junin virus infections.
Inventor(s): Clarke; Michael O' Neil Hanrahan (Redwood City, CA), Feng; Joy Yang (Hillsborough, CA), Jordan; Robert (Foster City, CA), Mackman; Richard L. (Millbrae, CA), Ray; Adrian S. (Burlingame, CA), Siegel; Dustin (Half Moon Bay, CA)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Application Number:16/863,566
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,007,208: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the details of United States Patent 11,007,208, exploring its claims, scope, and the broader patent landscape.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. The claims must be clear, concise, and supported by the patent specification[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These describe a process or method.
  • Apparatus Claims: These describe a device or system.

For US Patent 11,007,208, it is essential to identify the types of claims and their dependencies to understand the full scope of the invention.

Analyzing the Scope of the Patent

The scope of a patent is determined by its claims and is a critical factor in assessing its validity and enforceability.

Metrics for Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can indicate the breadth and complexity of the patent[5].

  • Independent Claim Length: Longer independent claims often indicate a narrower but more detailed scope.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, but may also indicate complexity and potential issues with clarity.

Impact on Patent Quality

The debate over patent quality often revolves around the breadth and clarity of patent claims. Broader claims can lead to increased licensing and litigation costs, potentially diminishing innovation incentives. Narrower claims, on the other hand, are associated with a higher probability of grant and a shorter examination process[5].

Patent Landscape Analysis

A patent landscape analysis provides a snapshot of the intellectual property outlook for a given technology, industry, or company.

Patent Classification

Patent classification systems, such as those used by the USPTO and international offices, organize patent documents into specific technology groupings. This helps in identifying relevant prior art and understanding the competitive landscape[4].

Global Dossier and International Search

To fully analyze the patent landscape, it is crucial to look beyond national borders. Tools like the Global Dossier and international patent databases (e.g., EPO's esp@cenet, JPO, WIPO's PATENTSCOPE) provide access to related applications and prior art from participating IP offices[1].

Tools and Resources for Patent Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and analyzing patent claims. It offers enhanced access to prior art through modern interfaces[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs provide training in patent search techniques and maintain local search resources, which can be invaluable for thorough patent analysis[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from IP5 Offices, allowing users to visualize search results for the same invention on a single page. This is particularly useful for international patent landscape analysis[1].

Case Studies and Legal Implications

Determining Inventorship

Correct inventorship is vital for the validity and enforceability of a patent. Errors in inventorship can lead to unenforceable patents, even if corrected later. The case of Frank’s Casing Crew v. PMR Technologies highlights the consequences of deceptive intent in naming inventors[2].

Changes in Inventorship

Inventorship can change during the prosecution of a patent application, especially when claims are amended or canceled. Ensuring accurate inventorship from the outset is crucial to avoid administrative and legal complications[2].

Key Takeaways

  • Clear and Concise Claims: Ensure that patent claims are well-defined and supported by the specification.
  • Patent Scope Metrics: Use metrics like independent claim length and count to assess the breadth and complexity of the patent.
  • Global Landscape Analysis: Utilize tools like Global Dossier and international patent databases to understand the broader patent landscape.
  • Accurate Inventorship: Determine inventorship accurately to avoid legal and administrative issues.
  • Continuous Monitoring: Regularly update and monitor patent claims and the patent landscape to maintain competitive advantage.

FAQs

Q: What are the key components of a patent claim?

A: The key components include independent and dependent claims, method claims, and apparatus claims, all of which must be clear, concise, and supported by the patent specification.

Q: How do you measure the scope of a patent?

A: Metrics such as independent claim length and independent claim count are commonly used to measure patent scope.

Q: Why is accurate inventorship important?

A: Accurate inventorship is crucial for the validity and enforceability of a patent. Errors can lead to unenforceable patents, even if corrected later.

Q: What tools are available for patent landscape analysis?

A: Tools include the USPTO's Patent Public Search, Global Dossier, and international patent databases like EPO's esp@cenet and WIPO's PATENTSCOPE.

Q: How can changes in claims affect inventorship?

A: Changes in claims, such as cancellations or amendments, can result in changes to the list of inventors, emphasizing the need for accurate inventorship determination throughout the patent application process.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Determining Inventorship for US Patent Applications: https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Patents - Library Guides at Brown University: https://libguides.brown.edu/patent
  5. Patent Claims and Patent Scope - SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,007,208

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gilead Sciences Inc VEKLURY remdesivir POWDER;INTRAVENOUS 214787-001 Oct 22, 2020 RX Yes Yes 11,007,208*PED ⤷  Subscribe Y ⤷  Subscribe
Gilead Sciences Inc VEKLURY remdesivir SOLUTION;INTRAVENOUS 214787-002 Oct 22, 2020 RX Yes Yes 11,007,208*PED ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,007,208

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016323604 ⤷  Subscribe
Australia 2020233714 ⤷  Subscribe
Australia 2023200990 ⤷  Subscribe
Brazil 112018005048 ⤷  Subscribe
Brazil 122020020217 ⤷  Subscribe
Canada 2998189 ⤷  Subscribe
China 108348526 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.